NRIX NASDAQ
Nurix Therapeutics, Inc.
1W: -0.1%
1M: -11.0%
3M: -4.4%
YTD: +27.3%
1Y: +144.6%
3Y: +176.3%
5Y: -30.0%
$22.99
-0.35 (-1.50%)
Weekly Expected Move ±5.2%
$21
$22
$23
$24
$25
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$37M
Revenue
-58.4% YoY
$-341M
Net Income
-64.6% YoY
$-305M
Free Cash Flow
-34.9% YoY
57.4%
Gross Margin
-1041.7%
Op. Margin
-990.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-80.3%
ROA-60.6%
ROIC-1655.0%
Valuation
P/E-6.7
P/B6.3
EV/EBITDA-5.0
Leverage
Debt/Equity0.14
Current Ratio6.34
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z4.65
Beneish M-6.39